Labs / ADME, DMPK & toxicology

Congruence
Montréal, QC, Canada · congruencetx.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Congruence Therapeutics is a clinical-stage biotechnology company that discovers and develops small molecule correctors and allosteric modulators for genetically validated human diseases caused by protein misfolding and abnormal signaling. It uses computational and experimental approaches to design and validate therapies for disease targets across metabolism, neurology, immunology, oncology, and rare diseases.
They take quote requests by email.
What they offer
Computational drug discovery platform (Revenir™)
Models proteins across multiple conformations to identify novel binding sites for small molecule drug design.
Small molecule discovery
Discovers novel small molecules that address disease at its molecular origin.
Experimental assay validation
Validates computational predictions through experimental assays.
Lead design for correctors and allosteric modulators
Rationally designs small molecules that correct protein structure and function.
What they work on
- Modalities
- Small molecule
- Assays and studies
- experimental assays, virtual screening
- Therapeutic areas
- metabolism, neurology, immunology, oncology, rare diseases, genetic obesity, GBA-associated Parkinson's disease, alpha-1 antitrypsin deficiency
- Address
- 6666 Saint-Urbain Street, Suite 450, Montreal, Quebec, H2S 3H1,Canada
Similar labs. Aclairo Pharmaceutical Development Group, Inc., ACM Global Laboratories, Allumiqs, Alpha Genesis, Inc.
Found in a contract services directory. Listing built from congruencetx.com. Work here? Claim this listing.